-
1 Comment
Henan Lingrui Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 12.6% above its 200 day moving average.
From a valuation standpoint, the stock is 77.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Henan Lingrui Pharmaceutical Co., Ltd's total revenue rose by 10.1% to $575M since the same quarter in the previous year.
Its net income has increased by 17.7% to $92M since the same quarter in the previous year.
Finally, its free cash flow grew by 36.8% to $115M since the same quarter in the previous year.
Based on the above factors, Henan Lingrui Pharmaceutical Co., Ltd gets an overall score of 5/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000001501 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.29 |
|---|---|
| Market Cap | 13B |
| PE Ratio | 17.76 |
| Target Price | 30.05 |
| Dividend Yield | None |
Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600285.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
